| |
¤j®a¤@°_»{ÃÑ¡u·R´þ¯f¡v¡I(%m:*3 ©¥x¥_¥«¨p¥ßÀR¤ß°ê¥Á¤¤¤p¾Ç¾\Ūºô¯¸ -- ¥x¥_¥«¨p¥ßÀR¤ß°ê¥Á¤¤¤p¾Ç¾\Ūºô¯¸¡@¡@ XKP*Z" 1.¦ó¿×«á¤Ñ§K¬Ì¯Ê¥F¯gÔ¸s(AIDS)¡H
µª¡G«á¤Ñ§K¬Ì¯Ê¥F¯gÔ¸s(Acquired Immunodeficiency Syndrome, AIDS)¡A«UºÙ·R´þ¯f¡A³oÓ¦WºÙ¨Ó¦Û1981¦~¦b¬ü°êµo²{¤@¸sì¥ý¨Åé°·§§ªº¦~»´¡B¨k¦P©ÊÅʪ̷P¬V¤FªÍÅnÂΪͪ¢¡B¤fµÄ©À¯]µß©M±w¦³¥dªi¦è¤ó¦×½Fµ¥¡C³o¨Ç¯e¯f¦b¹L¥h¦h¨£©ó§K¬Ì¯Ê¥Fªº±wªÌ¡A¨Ò¦p¡G¸~½F¯f±w±µ¨ü¤Æ¾ÇªvÀø©Î±µ¨ü§K¬Ì§í¨î¾¯ªvÀøªº¯f±w¡C¦Ó¬°¤F©M¥ý¤Ñ§K¬Ì¯Ê¥F°Ï¤À¡A¬GºÙ¬°«á¤Ñ§K¬Ì¯Ê¥F¯gÔ¸s¡C«á¤Ñ§K¬Ì¯Ê¥F¯gÔ¸s¬O·P¬V¤HÃþ§K¬Ì¯Ê¥F¯f¬r(Human Immunodeficiency Virus¡AHIV¡A«UºÙ·R´þ¯f¬r)ªº¥½´Áªí²{¡A¨ä¶EÂ_¼Ð·Ç¬°HIVªºÀËÅç¡]§ÜÅé¡B§Üì©Î¯f¬r°ö¾iµ¥¡^§e¶§©Ê¤ÏÀ³¥[¤W(1)CD4²O¤Ú²y¼Æ¤Ö©ó200Ó/²@¤É(2)¥X²{¬Y¨Ç¯S©wªº¦ø¾÷©Ê·P¬V¡B¯«¸g¨t²Î¯f¯g©Î¸~½F¡Ce
¡@2.¦ó¿×·R´þ¯f¬r¡]HIV¡^¡HW>##
µª¡GHIV¡]Human Immunodeficiency Virus¡^§Y¬O¤HÃþ§K¬Ì¯Ê¥F¯f¬r¡A«UºÙ·R´þ¯f¬r¡C¥Ø«e¥i¤À¬°¨â«¬¡AHIV-1©MHIV-2¡CHIV-1¬O¤j¦h¼Æ°ê®a¤¤³Ì¥Dn³y¦¨·R´þ¯fªº¯f¦]¡CHIV-2¥Dn¤À¥¬¦b¦è«D¡C¨âºØ¯f¬rªºP¯f¤O¨Ã¤£¬Û¦P¡A·P¬VHIV-1«á¶W¹L90%ªº±wªÌ·|¦b10-12¦~¤ºµo¯f¦¨¬°·R´þ¯f¡C·P¬VHIV-2«h©¹©¹¨S¦³¬ÛÃöªº¯f¯g¡C
¡@3.¦ó¿×ªÅµ¡´Á¡H¨ä¶¡·|¶Ç¬V¶Ü¡H
µª¡G·R´þ¯f¬r·P¬V«á¡A»Ýn¸g¹L¤@¬q®É¶¡¦å²G¤~·|²£¥Í·R´þ¯f¬r§ÜÅé¡A¦]¦¹¦b·P¬V«áªº¦´Á¡A¥i¯à¦]§ÜÅé©|¥¼²£¥Í¡A¦ÓÀËÅç§e³±©Ê¤ÏÀ³¡A¦¹§Y¬°ªÅµ¡´Á¡C¤@¯ë¦Ó¨¥¡AªÅµ¡´Á¬ù¬O·R´þ¯f¬r·P¬V«á6-12¶g¤º¡A¹L¥h¤]¦³¹s¬Pªº³ø§iµo²{ªÅµ¡´Áªø¹F12Ó¤ë¡CÀHµÛÀËÅç¤è¦¡ªº¶i¨B¡AªÅµ¡´Á¤w¥i¥HÁYµu¨ì1-2¬P´Á¡C¦b¦¹´Á¶¡¡A±wªÌÅ餺ªº·R´þ¯f¬r¯f¬r¶q³Ì°ª¡A¶Ç¬V¤O±j¡CªÅµ¡´Á®É³\¦h±wªÌ¨S¦³¯gª¬¡A©Î¬O¯gª¬¤£¯S®í¡A©ö³Q²¨©¿©Î¶EÂ_¦¨¤@¯ëªº·P«_¡A¦]¦¹±wªÌ¥i¯àÄ~Äò±q¨Æ°ª¦MÀI©Ê¦æ¬°¡B¶Ç¬V¨ä¥Lªº¤H¡C¥Ø«e·R´þ¯f¬rªº¬y¦æ¨Ã¥¼µy·²¡A³o¥i¯à¬Oì¦]¤§¤@¡Cpt
¡@4.¦ó¿×¼ç¥ñ´Á¡H¦³¦h¤[¡H
µª¡G·R´þ¯f¬r·P¬V«áªº¼ç¥ñ´Á¦³¤GºØ»¡ªkj (¤@)«ü·P¬V«á¬ù2-6¬P´Á·|¥X²{·P«_¼Ëªºìµo©Ê·P¬V¯gª¬,pE (¤G)«ü·P¬V·R´þ¯f¬r«á¨ì¥X²{Á{§É¯gª¬ªº´Á¶¡¡A¤@¯ë¬O5-10¦~(¥Ø«eºÙ¬°Áô§Î´Á©Î¦¸Á{§É´Á)¡C¦ý¬O¡A¦p«ez¡A·R´þ¯f¬r·P¬V«áªº¯fµ{§ÖºC¤£¤@¡CªÅµ¡´Á©Î¼ç¥ñ´Á®É¡A³\¦h±wªÌ¨S¦³¯gª¬¡A±wªÌ¥i¯àÄ~Äò±q¨Æ°ª¦MÀI¦æ¬°¡A¦]¦¹¦¨¬°·R´þ¯f¬r¨¾ªvªºº|¬}¡C
¡@5.·R´þ¯f¬r¦p¦ó¯}Ãa¤HÅé§K¬Ì¨t²Î¡H
µª¡G·R´þ¯f¬r¶i¤JCD4²O¤Ú²y«á¡A¦b²ÓM¤º§Q¥Î¥»¨¯S¦³ªº¤ÏÂà¿ý(Reversetranscriptase)§¹¦¨½Æ»s«á¡A·R´þ¯f¬rÁû²Éªº¥~®M©M²ÓM½¤¿Ä¦X¡B¬ï¹L²ÓM½¤¡BÂ÷¶}²ÓM¡C¯f¬r³y¦¨²ÓM¯}Ãa¸g¥Ñ¦hºØ¥i¯àªº¾÷Âà¡C¯f¬r³y¦¨²ÓM¶¡¿Ä¦X(Syncytia formation)¡A§í¨î²ÓM¤º³J¥Õ½èªº¦X¦¨¡B¦ÛÅé§K¬Ì¾÷Âà(Autoimmune mechanism)¡B²ÓMä¤`(Apoptosis)¡ACD8²O¤Ú²y¹ï©ó·P¬V¯f¬rªº²ÓM¤]·|¬I¥H¬r±þ¯}Ãaµ¥µ¥¡CCD4²O¤Ú²y·|¦A¤Àµõ¼W¥Í¥H¸É¥R¡A¦ý¬O¤Àµõªº²ÓM§ó®e©ö·P¬V¦Ó¯}Ãa¡A¨ä¯}Ãa³t«×¶W¹L¸É¥R³t«×¡A©ó¬OCD4²O¤Ú²y¼Æ¥Ø¤éº¥´î¤Ö¡C·íCD4²O¤Ú²y¦]·P¬V¯f¬r¦Ó¥\¯à§C¤U©Î¼Æ¥Ø°§C®É¡A§K¬Ì¨t²Î¥X²{°ÝÃD¡A¨ü¨ìCD4²O¤Ú²y«ü´§¡B¨ã¦³¯S²§©Êªº§K¬Ì¥\¯àªº²ÓM¡A¥]¬AT²O¤Ú²y©MB²O¤Ú²y¡A¥\¯à°§C¡A¦]¦¹¦ø¾÷©Ê·P¬V©M¸~½F«K±µ¿æ¦Ó¦Ü¡ChMJ/ !ff$,i ¡@6.¥¿±`¤HÅé¾D¦h¤Ö¼Æ¶q¤§·R´þ¯f¬r¤J«I¤~·|³y¦¨·P¬V¡H
µª¡G¦h¤Ö¯f¬r¶i¤J¤HÅé·|³y¦¨·P¬V¡A¨Ã¤£²M·¡¡A¦]¬°µLªk¹ê¬I¤HÅé¹êÅç¡A¦AªÌ¡A¯f¬r¶i¤J¬Y¨Ç¤HÅ餺¡A¥i¯àµLªkÁc´Þ¡A©Î³Q²M°£±¼¡A³¡¤À¾ÇªÌ¹w¦ô¬°5000Ó¯f¬r²É¤l(1000Ó¯f¬r¬°¤@¶Ç¬V³æ¦ì)¡A¥i¯à³y¦¨¤HÃþ·P¬V¡C¦¹¥~ª½±µ³Q·P¬V²ÓM«I¤J«h·P¬V²v¤j¼W¡CH
¡@7.T²ÓM¦b¤HÅé§K¬Ì¨t²Î¤¤§êºt¦óºØ¨¤¦â¡H
µª¡G¦b¤HÃþªº§K¬Ì¨t²Î¤¤¡A¨ã¦³¯S²§©Êªº§K¬Ì¦å²y¥]¬AT²O¤Ú²y©MB²O¤Ú²y¡C¥~¨Óªº§Üì¸g¬Y¨Ç§]¾½²ÓM³B²z«á¡A·|±N°T®§¶Ç¹Fµ¹»²§U«¬CD4²O¤Ú²y¡A¦AÂà¹F¨Ã¨ë¿EB²O¤Ú²y¥H²£¥Í§ÜÅé¡AºÙ¬°¼ß©Ê§K¬Ì(humoral immunity)¡A©Î¸g¥Ñ²ÓM¿E¯Àµ¥ª«½è±N°T®§¶Çµ¹¨ä¥¦ªº²ÓM¡A¨Ò¦p¡GCD4²O¤Ú²y¡BCD8²O¤Ú²y¡B³æ®Öªº§]¶Ý²ÓMµ¥¡A¤j®a¤@°_©è¿m¥~¨Óªº¯fì¡CCD8²O¤Ú²y¨ã¦³¬r±þ²ÓMªº¥\¯à¡A¦¹ºÙ¬°²ÓM©Ê§K¬Ì(cellular immunity)¡C©Ò¥H¡ACD4²O¤Ú²y¦³¦p¼Ö¹Îªº«ü´§¡A·íCD4²O¤Ú²y¦]·P¬V¦Ó¥\¯à§C¤U©Î¼Æ¥Ø°§C®É¡A§K¬Ì¨t²Î¥X²{°ÝÃD¡A·P¬V©M¸~½F«K±µ¿æ¦Ó¦Ü¡CS%RW
¡@8.¦ó¿×¤Ï¿ý¯f¬r¡H¦³¦ó¯S©Ê¡H
µª¡G¤Ï¿ý¯f¬r(Retroviruses)¦b±J¥D²ÓM¤º§Q¥Î¥»¨¯S¦³ªº¤ÏÂà¿ý(Reverse transcriptase)±N¥¦ªº¿ò¶Çª«½è(®Ö¿}®Ö»Ä¡ARNA)¤ÏÂà¿ý¦¨¥h®ñ®Ö¿}®Ö»Ä(DNA)«á´O¤J²ÓM®ÖªºDNA¤¤¡A¦ÓºÙ¬°¯f¬rì(Provirus)¡A¦Ó«á¦A§Q¥Î¯f¬rìÂà¿ý¦¨RNA¡A»s³y³J¥Õ½è©M¨ä¥¦¯f¬r½Æ»s©Ò»Ýªºª«½è¡C³o¤£¦P©ó¤@¯ëªº¯f¬r¡Aª½±µ§Q¥Î¦Û¤vªºDNAÂà¿ý¦¨RNA¨Ó¦X¦¨³J¥Õ½è¡C³o¤@Ãþ¦³¦Wªº¤HÃþ¤Ï¿ý¯f¬r¥]¬A¡GHuman T-lymphotropicvirus-I,II(HTLV-I,II)¤ÎHIV¡Cl
¡@9.·R´þ¯f¬r¦b¤HÅ餤¤§¥Í©R¶g´Á(LifeCycle)¡H
µª¡G·R´þ¯f¬r¶i¤J¤HÅé¦å²G«á¡A¸g¥Ñ¯f¬r¥~®Mªºgp120/41§Üì»P±a¦³CD4¤À¤lªº¦å²y(CD4²O¤Ú²y¡B³æ®Öªº§]¾½²ÓM)©Î¨ä¥Lªº¨Åé²ÓMµ²¦X«á¡A¶i¤J²ÓM¤º¡A¨ÃÄÀ©ñ¥XRNA¡C¦b²ÓM¤º¡A·R´þ¯f¬r§Q¥Î¥»¨¯S¦³ªº¤ÏÂà¿ý(reverse transcriptase)±N¥¦ªº¿ò¶Çª«½è(®Ö¿}®Ö»Ä¡ARNA)¤ÏÂà¿ý¦¨¥h®ñ®Ö¿}®Ö»Ä(DNA)«á´O¤J²ÓM®ÖªºDNA¤¤¡C¦Ó«á·R´þ¯f¬r¦A§Q¥Î¦¹DNAÂà¿ý¦¨RNA¡A»s³y³J¥Õ½è©M¨ä¥¦¯f¬r½Æ»s©Ò»Ýªºª«½è¡C«Ý¸Ë°t§¹¦¨«á¡A·R´þ¯f¬rÁû²Éªº¥~®M©M²ÓM½¤¿Ä¦X¡A¬ï¹L²ÓM½¤¡CÂ÷¶}«e¡A·R´þ¯f¬rÁû²É¤º³¡ªº³J¥Õ«hÄ~Äò¤u§@¡A±N¤jªº³J¥ÕÃì¤ÁÂ_¦¨¬°³\¦h¹ï·R´þ¯f¬r½Æ»s«Ü«nªº³J¥Õ¤ùÂ_¡C¾ãÓcycle¬ù¶·2.2¤Ñ¡C\h
ºK¦Ûwww.avert.org
TFyCI
| | |
|
|
|